PuSH - Publication Server of Helmholtz Zentrum München: The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Hohenauer, Z.* ; Berking, C.* ; Schmidt, A.* ; Haferkamp, S.* ; Senft, D.* ; Kammerbauer, C.* ; Fraschka, S.* ; Graf, S.A.* ; Irmler, M. ; Beckers, J. ; Flaig, M.* ; Aigner, A.* ; Höbel, S.* ; Hoffmann, F.* ; Hermeking, H.* ; Rothenfusser, S.* ; Endres, S.* ; Ruzicka, T.* ; Besch, R.*

The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.

EMBO Mol. Med. 5, 919-934 (2013)

Publ. Version/Full Text PDF

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

Pigment cells and neuronal cells both are derived from the neural crest. Here, we describe the Pit-Oct-Unc (POU) domain transcription factor Brn3a, normally involved in neuronal development, to be frequently expressed in melanoma, but not in melanocytes and nevi. RNAi-mediated silencing of Brn3a strongly reduced the viability of melanoma cell lines and decreased tumour growth in vivo. In melanoma cell lines, inhibition of Brn3a caused DNA double-strand breaks as evidenced by Mre11/Rad50-containing nuclear foci. Activated DNA damage signalling caused stabilization of the tumour suppressor p53, which resulted in cell cycle arrest and apoptosis. When Brn3a was ectopically expressed in primary melanocytes and fibroblasts, anchorage-independent growth was increased. In tumourigenic melanocytes and fibroblasts, Brn3a accelerated tumour growth in vivo. Furthermore, Brn3a cooperated with proliferation pathways such as oncogenic BRAF, by reducing oncogene-induced senescence in non-malignant melanocytes. Together, these results identify Brn3a as a new factor in melanoma that is essential for melanoma cell survival and that promotes melanocytic transformation and tumourigenesis.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

7.795

1.771